Company Filing History:
Years Active: 2016
Title: The Innovations of Albert Collinson
Introduction
Albert Collinson is a notable inventor based in Marlborough, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of high affinity adaptor molecules. His work has the potential to enhance the specificity of antibodies, which is crucial for various therapeutic applications.
Latest Patents
Collinson holds a patent for "High affinity adaptor molecules for redirecting antibody specificity." This patent discloses methods for identifying high affinity adaptor molecules that bind to both a circulating antibody and a target molecule. The innovation allows for the redirection of the specificity of the circulating antibody to the target molecule, providing a new avenue for targeted therapies. Exemplary high affinity adaptor molecules are also included in the patent.
Career Highlights
Collinson is currently associated with Tripep Ab, a company focused on advancing biopharmaceuticals. His work at Tripep Ab has been instrumental in pushing the boundaries of antibody technology. With a strong background in biochemistry, he has dedicated his career to improving therapeutic strategies through innovative solutions.
Collaborations
Collinson has collaborated with notable colleagues such as Peter Wagner and Matti Sällberg. These collaborations have fostered a productive environment for research and development, leading to advancements in their respective fields.
Conclusion
Albert Collinson's contributions to the field of biotechnology through his innovative patent and work at Tripep Ab highlight his role as a significant inventor. His efforts in developing high affinity adaptor molecules are paving the way for future advancements in targeted therapies.